Acute laryngotracheobronchitis treated with 0-125% superinone.
D003440:Croup / Q000628:therapy*; D011092:Polyethylene Glycols; D013501:Surface-Active Agents / Q000627:therapeutic use*
D013501:Surface-Active Agents; D011092:Polyethylene Glycols; C016811:tyloxapol
CROUP/therapy; SURFACE-ACTIVE SUBSTANCES/therapeutic use